Extracorporeal Membrane Oxygenation Machine Market Share, Trends Analysis, Growth and Forecast 2023-2028

IMARC Group, a leading market research company, has recently released a report titled “Extracorporeal Membrane Oxygenation Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global extracorporeal membrane oxygenation machine market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How Big is the Extracorporeal Membrane Oxygenation Machine Market?

Global extracorporeal membrane oxygenation machine market is expected to exhibit a growth rate (CAGR) of 5.1% during 2023-2028.

Request For a Free PDF Sample Report: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market/requestsample

What is Extracorporeal Membrane Oxygenation Machine?

The extracorporeal membrane oxygenation (ECMO) machine represents miniaturized heart-lung equipment used to support respiratory and cardiac functions during transplant surgeries. It drains the blood and removes carbon dioxide from the body of the patient to artificially oxygenate the red blood cells. ECMO is also utilized in late-stage treatments or post-cardiopulmonary bypass with heart or lung failure. It is commonly available in Veno-Venous (VV) and Veno-Arterial (VA). VV includes attaching cannulas to large veins in the body to drain the blood and detach the carbon dioxide, thereby providing support only to the lungs. Whereas VA ECMO is used to support the functioning of the heart and lungs by draining and pumping the blood throughout the body.

What are the Growth Prospects and Trends in the Extracorporeal Membrane Oxygenation Machine Industry?

The growing prevalence of respiratory and cardiovascular disorders across the globe is primarily driving the extracorporeal membrane oxygenation machine market. Furthermore, the widespread adoption of ECMO for adults, newborns, and children suffering from cardiac failure, on account of congenital disabilities, trauma, or severe infections, is also augmenting the market growth. Apart from this, the expanding geriatric population that is prone to chronic medical ailments is positively influencing the global market. Moreover, the increasing patient awareness regarding the benefits of timely ECMO procedures is further bolstering the market growth. Besides this, technological advancements, such as the introduction of polymethyl pentene (PMP) fiber-based artificial membranes with low resistance and improved biocompatibility, are acting as significant growth-inducing factors. Additionally, equipment manufacturers are launching compact ECMO machines for enhanced portability and convenient oxygenation of the blood, which is also catalyzing the global market. In addition to this, rising healthcare expenditure capacities of consumers and extensive research and development (R&D) activities are expected to drive the extracorporeal membrane oxygenation machine market.

Buy This Report Now: https://www.imarcgroup.com/checkout?id=3805&method=1

Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.

Who are the Key Players Operating in the Extracorporeal Membrane Oxygenation Machine Market?

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• Abbott Laboratories
• ALung Technologies Inc.
• Braile Biomedical
• Eurosets, LivaNova PLC
• Medtronic
• MicroPort Scientific Corporation
• Nipro Medical Corporation
• Origen Biomedical, Inc.
• Terumo Corporation
• Xenios AG.

What is Included in Market Segmentation?

The report has categorized the market based on component, modality, patient type and application.

Breakup by Component:

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

Based on Modality:

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

Analysed by Patient Type:

• Neonates
• Pediatric
• Adult

Applications:

• Respiratory
• Cardiac
• ECPR

Regional Analysis:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market

Key Highlights of the Report:                                                     

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

https://nyasowi.com/read-blog/3772_3d-printing-market-trends-analysis-growth-and-forecast-2023-2028.html

https://nyasowi.com/read-blog/3773_digital-health-market-size-trends-growth-and-forecast-by-2027.html

https://nyasowi.com/read-blog/3774_heat-pumps-market-size-trends-growth-and-analysis-by-2027.html

https://nyasowi.com/read-blog/3775_homeland-security-market-size-trends-growth-and-forecast-by-2027.html

https://nyasowi.com/read-blog/3963_hydrodesulfurization-catalysts-market-trends-key-players-segmentation-and-foreca.html

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800